Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $588,008 - $765,956
4,248 New
4,248 $600,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $427,198 - $682,287
2,663 New
2,663 $498,000
Q1 2022

May 13, 2022

SELL
$161.19 - $257.96 $3,707 - $5,933
-23 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$247.59 - $304.47 $5,694 - $7,002
23 New
23 $6,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.